American Tower Corporation
175.43USD
-0.3000 (-0.17%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.64▲ | $1.58 | 7 | 0 |
| Next quarter | $1.66▲ | $1.61 | 6 | 0 |
| Current year | $6.98▲ | $6.6 | 7 | 0 |
| Next year | $7.01▲ | $6.87 | 4 | 4 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.55 | $1.87 | +0.32 (+20.7%) |
| 2026-03-31 | $1.57 | $1.84 | +0.27 (+17.0%) |
| 2025-12-31 | $1.47 | $1.75 | +0.28 (+19.1%) |
| 2025-09-30 | $1.65 | $1.82 | +0.17 (+10.1%) |
362 ratings from 43 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Barclays | Upgraded from Equal-Weight | Overweight | $195 $198 | Aug 20, 2026 |
| Truist Securities | Reiterated | Buy | $208 $207 | Aug 12, 2026 |
| TD Cowen | Maintained | Buy | $225 $227 | Jul 29, 2026 |
| BMO Capital | Maintained | Market Perform | $190 $195 | Jul 29, 2026 |
| Wolfe Research | Upgraded from Peer Perform | Outperform | $188 | Jul 9, 2026 |
| RBC Capital | Upgraded from Sector Perform | Outperform | $195 $205 | Jun 26, 2026 |
| Bernstein | Upgraded from Market Perform | Outperform | $207 | May 19, 2026 |
| RBC Capital | Reiterated | Sector Perform | $195 | Apr 30, 2026 |
| Truist Securities | Maintained | Buy | $205 $208 | Apr 30, 2026 |
| JP Morgan | Maintained | Overweight | $245 $240 | Apr 29, 2026 |
| Scotiabank | Maintained | Sector Outperform | $214 $218 | Apr 29, 2026 |
| Citizens | Reiterated | Market Outperform | $260 | Apr 29, 2026 |
| Barclays | Maintained | Equal-Weight | $200 $195 | Apr 16, 2026 |
| Mizuho | Upgraded from Neutral | Outperform | $189 $205 | Apr 15, 2026 |
| Truist Securities | Initiated | Buy | $205 | Mar 31, 2026 |
| Bernstein | Initiated | Market Perform | $205 | Mar 5, 2026 |
| UBS | Maintained | Buy | $254 $248 | Feb 25, 2026 |
| Scotiabank | Maintained | Sector Outperform | $220 $214 | Feb 25, 2026 |
| Morgan Stanley | Maintained | Overweight | $225 $220 | Feb 25, 2026 |
| UBS | Maintained | Buy | $260 $254 | Jan 20, 2026 |
| Scotiabank | Maintained | Sector Outperform | $248 $220 | Jan 14, 2026 |
| JP Morgan | Maintained | Overweight | $250 $245 | Jan 12, 2026 |
| Mizuho | Maintained | Neutral | $217 $189 | Jan 12, 2026 |
| BMO Capital | Downgraded from Outperform | Market Perform | $210 $185 | Jan 9, 2026 |
| RBC Capital | Reiterated | Sector Perform | $220 | Dec 19, 2025 |
74 filings from 21 insiders · 21 buy / 3 sell over 6m
Officers and directors of AMT, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| KALATHUR RAJESHDirector | Buy | 2.8k | $177.00 | $501k | Aug 21, 2026 |
| DOWLING RUTH TGeneral Counsel | Sell | 1.8k | $169.54 | $310k | Jul 29, 2026 |
| MEYER ROBERT JOSEPH JROfficer | Sell | 5.0k | $178.89 | $894k | Jul 29, 2026 |
| REEVE PAMELA D ADirector | Gift | 810 | — | — | May 28, 2026 |
| DOWLING RUTH TOfficer | Sell | 972 | $177.54 | $173k | Apr 29, 2026 |
| KALATHUR RAJESHDirector | Buy | 2.7k | $185.30 | $495k | Mar 10, 2026 |
| MACNAB CRAIGDirector | Grant | 1.2k | — | — | Mar 10, 2026 |
| HORMATS ROBERT D.Director | Grant | 1.2k | — | — | Mar 10, 2026 |
| CLARKE TERESA HILLARYDirector | Grant | 1.2k | — | — | Mar 10, 2026 |
| DOWLING RUTH TGeneral Counsel | Grant | 6.9k | — | — | Mar 10, 2026 |
| NOEL EUGENE MChief Operating Officer | Grant | 8.2k | — | — | Mar 10, 2026 |
| ROSSI RICHARD COfficer | Grant | 6.4k | — | — | Mar 10, 2026 |
| REILLY EUGENE FDirector | Grant | 1.2k | — | — | Mar 10, 2026 |
| MEYER ROBERT JOSEPH JROfficer | Grant | 4.0k | — | — | Mar 10, 2026 |
| TANNER BRUCE LDirector | Grant | 1.2k | — | — | Mar 10, 2026 |
| KALATHUR RAJESHDirector | Grant | 1.2k | — | — | Mar 10, 2026 |
| LIEBLEIN GRACE DDirector | Grant | 1.2k | — | — | Mar 10, 2026 |
| RAY NEVILLE R.Director | Grant | 1.2k | — | — | Mar 10, 2026 |
| CHAMBLISS KELLY C.Director | Grant | 1.2k | — | — | Mar 10, 2026 |
| FONT JUAN HERNANDEZOfficer | Grant | 8.1k | — | — | Mar 10, 2026 |
No analyst notes on AMT yet.
Analyst Ratings
23 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 7 | 15 | 3 | 0 | 0 | Buy1.84 |
| 1 mo ago | 7 | 15 | 3 | 0 | 0 | Buy1.84 |
| 2 mo ago | 6 | 15 | 4 | 0 | 0 | Buy1.92 |
| 3 mo ago | 6 | 14 | 5 | 0 | 0 | Buy1.96 |